172 related articles for article (PubMed ID: 18803862)
1. A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
Oldenbeuving AW; de Kort PL; Jansen BP; Kappelle LJ; Roks G
BMC Neurol; 2008 Sep; 8():34. PubMed ID: 18803862
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke].
Litvineneko IV; Odinak MM; Khlystov IuV; Perstnev SV; Fedorov BB
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):36-41. PubMed ID: 21389938
[TBL] [Abstract][Full Text] [Related]
3. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine in the treatment of delirium in older people: a pilot study.
Overshott R; Vernon M; Morris J; Burns A
Int Psychogeriatr; 2010 Aug; 22(5):812-8. PubMed ID: 20353624
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease.
Narasimhalu K; Effendy S; Sim CH; Lee JM; Chen I; Hia SB; Xue HL; Corrales MP; Chang HM; Wong MC; Chen CP; Tan EK
Acta Neurol Scand; 2010 Apr; 121(4):217-24. PubMed ID: 19951274
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G
Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's drug proves ineffective for delirium.
Harv Ment Health Lett; 2011 Mar; 27(9):7. PubMed ID: 21476248
[No Abstract] [Full Text] [Related]
8. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.
Gamberini M; Bolliger D; Lurati Buse GA; Burkhart CS; Grapow M; Gagneux A; Filipovic M; Seeberger MD; Pargger H; Siegemund M; Carrel T; Seiler WO; Berres M; Strebel SP; Monsch AU; Steiner LA
Crit Care Med; 2009 May; 37(5):1762-8. PubMed ID: 19325490
[TBL] [Abstract][Full Text] [Related]
9. Rivastigmine in vascular dementia.
Vincent S; Lane R
Int Psychogeriatr; 2003; 15 Suppl 1():201-5. PubMed ID: 16191241
[TBL] [Abstract][Full Text] [Related]
10. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.
Scicutella A
J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514
[No Abstract] [Full Text] [Related]
11. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
[TBL] [Abstract][Full Text] [Related]
12. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
[TBL] [Abstract][Full Text] [Related]
13. Do local meteorological conditions influence skin irritation caused by transdermal rivastigmine? A retroprospective, pilot study.
Segers K; Cytryn E; Surquin M
J Clin Psychopharmacol; 2012 Jun; 32(3):412-5. PubMed ID: 22544007
[TBL] [Abstract][Full Text] [Related]
14. An open-label pilot study of the use of rivastigmine to promote functional recovery in patients with unilateral spatial neglect due to first ischemic stroke.
Paolucci S; Bureca I; Multari M; Nocentini U; Matano A
Funct Neurol; 2010; 25(4):195-200. PubMed ID: 21388579
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
Kalisvaart CJ; Boelaarts L; de Jonghe JF; Hovinga IM; Kat MG
Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1501-4. PubMed ID: 15481575
[TBL] [Abstract][Full Text] [Related]
16. Rivastigmine for cognitive impairment after spontaneous subarachnoid haemorrhage: a pilot study.
Wong GK; Wong R; Mok V; Wong A; Fan D; Leung G; Chan A; Poon WS
J Clin Pharm Ther; 2009 Dec; 34(6):657-63. PubMed ID: 20175798
[TBL] [Abstract][Full Text] [Related]
17. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
Gauthier S; Juby A; Morelli L; Rehel B; Schecter R;
Curr Med Res Opin; 2006 Nov; 22(11):2251-65. PubMed ID: 17076986
[TBL] [Abstract][Full Text] [Related]
18. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine in the treatment of postoperative delirium: a pilot clinical trial.
Zaslavsky A; Haile M; Kline R; Iospa A; Frempong-Boadu A; Bekker A
Int J Geriatr Psychiatry; 2012 Sep; 27(9):986-8. PubMed ID: 22886871
[No Abstract] [Full Text] [Related]
20. Cholinesterase inhibitor initiation in hospital setting.
Wagle KC; Taffet GE; Natali B
J Am Geriatr Soc; 2011 Oct; 59(10):1988-9. PubMed ID: 22091527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
